Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mediwound Ltd Ord Sh (MDWD)

Mediwound Ltd Ord Sh (MDWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 216,042
  • Shares Outstanding, K 12,852
  • Annual Sales, $ 16,960 K
  • Annual Income, $ -23,880 K
  • EBIT $ -25 M
  • EBITDA $ -23 M
  • 60-Month Beta 0.15
  • Price/Sales 12.28
  • Price/Cash Flow N/A
  • Price/Book 4.76

Options Overview Details

View History
  • Implied Volatility 57.14% (-8.99%)
  • Historical Volatility 41.12%
  • IV Percentile 14%
  • IV Rank 13.32%
  • IV High 158.87% on 03/04/26
  • IV Low 41.51% on 07/11/25
  • Expected Move (DTE 11) 1.15 (6.95%)
  • Put/Call Vol Ratio 1.39
  • Today's Volume 270
  • Volume Avg (30-Day) 225
  • Put/Call OI Ratio 1.01
  • Today's Open Interest 1,519
  • Open Int (30-Day) 2,534
  • Expected Range 15.37 to 17.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.65
  • Number of Estimates 6
  • High Estimate $-0.61
  • Low Estimate $-0.73
  • Prior Year $-0.07
  • Growth Rate Est. (year over year) -828.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.90 +11.34%
on 03/30/26
17.63 -5.90%
on 04/06/26
-0.44 (-2.58%)
since 03/06/26
3-Month
14.90 +11.34%
on 03/30/26
19.70 -15.79%
on 01/08/26
-2.20 (-11.71%)
since 01/06/26
52-Week
14.14 +17.33%
on 04/07/25
22.50 -26.28%
on 06/02/25
+1.62 (+10.82%)
since 04/04/25

Most Recent Stories

More News
MediWound: Q4 Earnings Snapshot

MediWound: Q4 Earnings Snapshot

MDWD : 16.67 (-0.83%)
MediWound: Q3 Earnings Snapshot

MediWound: Q3 Earnings Snapshot

MDWD : 16.67 (-0.83%)
MediWound: Q2 Earnings Snapshot

MediWound: Q2 Earnings Snapshot

MDWD : 16.67 (-0.83%)
MediWound (MDWD) Q1 2025 Earnings Call Transcript

MDWD : 16.67 (-0.83%)
MediWound: Q1 Earnings Snapshot

MediWound: Q1 Earnings Snapshot

MDWD : 16.67 (-0.83%)
MediWound: Q4 Earnings Snapshot

MediWound: Q4 Earnings Snapshot

MDWD : 16.67 (-0.83%)
MediWound Ltd. Advances Development with EscharEx IND Submission Planned for Year-End and NexoBrid FDA Pediatric Approval

MediWound announces NexoBrid pediatric approval, EscharEx trial launch, financing secured, and exceeding product demand as manufacturing expands.Quiver AI SummaryMediWound Ltd. recently announced significant...

MDWD : 16.67 (-0.83%)
MediWound: Q3 Earnings Snapshot

MediWound: Q3 Earnings Snapshot

MDWD : 16.67 (-0.83%)
MediWound: Q2 Earnings Snapshot

MediWound: Q2 Earnings Snapshot

MDWD : 16.67 (-0.83%)
MediWound: Q1 Earnings Snapshot

MediWound: Q1 Earnings Snapshot

MDWD : 16.67 (-0.83%)

Business Summary

MediWound Ltd. is a biotechnology niche specialty company. It is focused on developing, manufacturing and commercializing products that address unmet needs in the fields of severe burn and chronic wound management. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue...

See More

Key Turning Points

3rd Resistance Point 19.74
2nd Resistance Point 18.64
1st Resistance Point 17.72
Last Price 16.67
1st Support Level 15.70
2nd Support Level 14.60
3rd Support Level 13.68

See More

52-Week High 22.50
Fibonacci 61.8% 19.31
Fibonacci 50% 18.32
Fibonacci 38.2% 17.34
Last Price 16.67
52-Week Low 14.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.